Furthermore, we demonstrated that GRO intervention inhibited the profibrotic phenotypes promoted by FBLN7 overexpression in aging CFs, as well as diastolic dysfunction and myocardial fibrosis in aging mice. Here, CXCL1 is linked to Myocardial fibrosis.